The profits from selling drugs in EU is more than enough for the cost of research. The US market prices are higher since the US market has higher sales costs (n

The profits from selling drugs in EU is more than enough for the cost of research. The US market prices are higher since the US market has higher sales costs (need to spend more ads and marketing dollars, and need to negotiate with all the insurers etc). Banning prescribed medicine ads and fixing the overly complicated healthcare system would help a lot keeping costs down and it wouldn't affect how much there is left over for research at all. https://truecostofhealthcare.org/wp-content/uploads/2019/03/PharmBG2018.png https://truecostofhealthcare.org/wp-content/uploads/2019/03/... https://truecostofhealthcare.org/the_pharmaceutical_industry/ https://truecostofhealthcare.org/the_pharmaceutical_industry...